In the hematopoietic system, immunohistochemical studies demonstrate that IGF2BP3 is highly expressed in various mature B-cell neoplasms and differential regulation of this protein has been observed in B-ALL [144, 146]. Here, IGF2BP3 is linked to precursor B-cell acute lymphoblastic leukemia.